Aspira Women S Health Inc (AWHL) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Aspira Women s Health inc   (AWHL)
 

Aspira Women S Health Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aspira Women S Health Inc inventory turnover ratio, the Aspira Women S Health Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 22.57 in the second quarter 2026, AWHL's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Aspira Women S Health Inc in Jun 30 2026 quarter, has decreased to 16 days, compare to 19 days, in the Mar 31 2026 quarter.

Within Healthcare sector 10 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 215, from total ranking in the first quarter 2026 at 242.

AWHL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aspira Women S Health Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AWHL Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -15.38 % 12.31 % -21.47 % -2.76 % 20.8 %
Y / Y Cost of Sales Growth 271.95 % 24.62 % -8.14 % 275.5 % -75.4 %
Inventory Turnover Ratio (TTM) 22.57 19.29 19.2 18.27 9.49
AWHL's Total Ranking # 215 # 242 # 233 # 433 # 318
Average inventory processing period 16 19 19 20 38
Seq. Inventory Growth -20.89 % 14.06 % -9.22 % 3.3 % 5 %
Seq. Cost of Sales Growth 2.12 % 13.42 % -76.68 % 1276.83 % -65.79 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 0
Healthcare Sector # 11
Overall Market # 215

Inventory Turnover Ratio Statistics
High Average Low
68.5 -1164.9 -14350.69
(Jun 30 2020)   (Dec 31 2020)



AWHL Company Profile >> Back to AWHL Efficiency Comparisons >> Compare AWHL Inventory Turnover Ratio to its Competitors

Financial Statements
Aspira Women S Health Inc 's Inventories $ 0 Millions Visit AWHL's Balance sheet
Aspira Women S Health Inc 's Cost of Revenues TTM $ 6 Millions Visit AWHL's Income Statement
What are AWHL's Sales? Visit AWHL's Sales by Segment

Other Inventory Turnover Ratios
Aspira Women S Health Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AWHL's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AWHL's Competitors
Inventory Turnover Ratio for AWHL's Suppliers
Inventory Turnover Ratio for AWHL's Customers

You may also want to know
AWHL's Sales Growth Rates AWHL's Pe Price to earnings ratio AWHL's Receivables Turnover Ratio AWHL's Stock Quote
AWHL's Net Income Growth Rates AWHL's Ps Price to Sales ratio AWHL's Sales per Employee AWHL's Asset Turnover Ratio
AWHL's Net Margin AWHL's Pb Price to Book ratio AWHL's Financial Strength Ratios AWHL's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Harmony Biosciences Holdings inc   39.56 $ 236.198  Millions$ 6  Millions
Qhslab Inc   39.48 $ 0.975  Millions$ 0  Millions
Quest Diagnostics Inc  37.13 $ 7,732.000  Millions$ 208  Millions
Vaso Corporation  33.32 $ 28.238  Millions$ 1  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Aspira Women s Health inc   22.57 $ 5.988  Millions$ 0  Millions
Prophase Labs Inc   22.13 $ 2.633  Millions$ 0  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Adapthealth Corp   18.95 $ 2,676.899  Millions$ 141  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Edap Tms Sa  12.79 $ 62.351  Millions$ 5  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Adaptive Biotechnologies Corporation  7.26 $ 75.254  Millions$ 10  Millions
Adm Tronics Unlimited Inc   6.05 $ 1.970  Millions$ 0  Millions
Sharps Technology Inc   5.68 $ 2.869  Millions$ 1  Millions
Transmedics Group Inc   5.59 $ 276.120  Millions$ 49  Millions
Opko Health Inc   5.42 $ 348.206  Millions$ 64  Millions

Date modified: 2026-08-30T14:50:02+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.